Literature DB >> 6605980

Soluble suppressor factors in patients with acquired immune deficiency syndrome and its prodrome. Elaboration in vitro by T lymphocyte-adherent cell interactions.

J Laurence, A B Gottlieb, H G Kunkel.   

Abstract

Supernatants from peripheral blood mononuclear cells obtained from certain patients with the acquired immune deficiency syndrome (AIDS) or its prodrome were capable of depressing spontaneous and pokeweed mitogen-driven B lymphocyte differentiation into plasmacytes, and the proliferative responses of T cells to specific antigen. These soluble suppressor factors (SSF) were present in uniquely high concentrations, with significant differences from healthy controls and from patients with various other conditions previously associated with factor-mediated immunosuppression. T cell-independent functions were not modified by SSF. Suppression was not genetically constrained, and did not appear to be mediated by cytotoxicity, prostaglandin, or alpha or gamma interferons. SSF was a product of the interaction of T lymphocytes with adherent cells. T cells or T cell factors from AIDS patients, but not from normal controls, could collaborate with control adherent cells in the formation of SSF. Restoration of DNA synthesis-independent differentiation of B lymphocytes into plasmacytes in SSF-treated cultures was realized by addition of reducing agents, such as 2-mercaptoethanol, on culture initiation. These data suggest inhibitory mechanisms possibly related to that of concanavalin A-induced soluble immune response suppression, and perhaps offer clues to clinically applicable substances which are potentially capable of mitigating such responses.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6605980      PMCID: PMC437048          DOI: 10.1172/JCI111172

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Interaction between T cells and non-T cells in suppression of cytotoxic lymphocyte responses.

Authors:  G A Truitt; D K Dennison; R R Rich; S S Rich
Journal:  J Immunol       Date:  1979-08       Impact factor: 5.422

2.  Immunosuppression in man: suppression by macrophages can be mediated by interactions with regulatory T cells.

Authors:  J D Stobo
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

3.  Mode of action of a soluble immune response suppressor (SIRS) produced by concanavalin a-activated spleen cells.

Authors:  T Tadakuma; C W Pierce
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

4.  Prevention of autoimmunity in experimental lupus erythematosus by soluble immune response suppressor.

Authors:  R S Krakauer; W Strober; D L Rippeon; T A Waldmann
Journal:  Science       Date:  1977-04-01       Impact factor: 47.728

5.  A plaque assay for all cells secreting Ig of a given type or class.

Authors:  E Gronowicz; A Coutinho; F Melchers
Journal:  Eur J Immunol       Date:  1976-08       Impact factor: 5.532

6.  Phorbolester-treated human lymphocytes are susceptible to natural killer cell-mediated cytolysis.

Authors:  D Kabelitz; H G Kunkel
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

7.  Suppressor thymus-derived lymphocytes in fungal infection.

Authors:  J D Stobo; S Paul; R E Van Scoy; P E Hermans
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

8.  Immune responses in vitro. 3. Development of primary gamma-M, gamma-G, and gamma-A plaque-forming cell responses in mouse spleen cell cultures stimulated with heterologous erythrocytes.

Authors:  C W Pierce; B M Johnson; H E Gershon; R Asofsky
Journal:  J Exp Med       Date:  1971-08-01       Impact factor: 14.307

9.  Appearance of peroxidase reactivity within the rough endoplasmic reticulum of blood monocytes after surface adherence.

Authors:  P T Bodel; B A Nichols; D F Bainton
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

10.  Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages.

Authors:  J I Kurland; R Bockman
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

View more
  38 in total

Review 1.  Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date.

Authors:  E G Sandström; J C Kaplan
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

Review 2.  Retrovirus and filovirus "immunosuppressive motif" and the evolution of virus pathogenicity in HIV-1, HIV-2, and Ebola viruses.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

3.  Malignant rabbit fibroma syndrome. A possible model for acquired immunodeficiency syndrome (AIDS).

Authors:  D S Strayer; S Sell; J L Leibowitz
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

4.  Monocyte function in intravenous drug abusers with lymphadenopathy syndrome and in patients with acquired immunodeficiency syndrome: selective impairment of chemotaxis.

Authors:  G Poli; B Bottazzi; R Acero; L Bersani; V Rossi; M Introna; A Lazzarin; M Galli; A Mantovani
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

5.  Treatment of the acquired immune deficiency syndrome.

Authors:  S Gupta; M S Gottlieb
Journal:  J Clin Immunol       Date:  1986-05       Impact factor: 8.317

6.  Impairment in T-lymphocyte responses during early infection with the human immunodeficiency virus.

Authors:  J Bentin; C D Tsoukas; J A McCutchan; S A Spector; D D Richman; J H Vaughan
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

7.  A factor from CD8 cells of human immunodeficiency virus-infected patients suppresses HLA self-restricted T helper cell responses.

Authors:  M Clerici; E Roilides; C S Via; P A Pizzo; G M Shearer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

8.  Relationship between IL-2 receptor expression and proliferative responses in lymphocytes from HIV-1 seropositive homosexual men.

Authors:  R K Chopra; N B Raj; J P Scally; A D Donnenberg; W H Adler; A J Saah; J B Margolick
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

Review 9.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

10.  Biological and biochemical characterization of a factor produced spontaneously by adherent cells of human immunodeficiency virus-infected patients inhibiting interleukin-2 receptor alpha chain (Tac) expression on normal T cells.

Authors:  A Ammar; C Cibert; A M Bertoli; V Tsilivakos; C Jasmin; V Georgoulias
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.